Triak Endovascular LLC (formally TempuStent)

TempuScore/TempuStent are hybrid medical devices that sustain the good and eliminate the bad of PTA and Stenting of leg plaque. 5 issued patents. $1.8B market.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Salt Lake City, UT, USA
  • Currency USD
  • Founded October 2018
  • Employees 0
  • Incorporation Type LLC
  • Website N

Company Summary

Direct sales to hospitals and physicians.

There are 3 co-founders with 100-years of combined medical device experience.

We are structured as an LLC to facilitate an eventual asset purchase.

We have 1 product with 2 use cases: TempuScore and TempuStent.

We are in early development with a proof of concept prototype and 5 issued patents.

65% gross margin at launch.

Team

Advisors

  • Bob Mitchell
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free